Global Lymphedema Treatment Market Size study, by Treatment Type (Compression Therapy, Surgery, Drug Therapy, Laser Therapy and Others) by Type (Primary Lymphedema and Secondary Lymphedema) by Affected Area (Genital, Lower Extremity, Upper Extremity and Others) by Age Group (Adult and Geriatric) by Route of Administration (Oral, Injectable and Others) by End User (Hospitals, Ambulatory Surgical Centers, Speciality Clinics and Others) by Distribution Channel (Direct Tender, Pharmacy Stores, and Others) and Regional Forecasts 2021-2027
- BIZ4728689
- 200 Pages
- December 2021
- Pharmaceuticals
The key regions considered for the global Lymphedema Treatment market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is to dominate the market lymphedema treatment market in the forecasted period. As there is increase in prevalence of breast cancer in the region. For instance, according to the Lymphatic Education & Research Network, approximately 10 million Americans suffer from lymphedema and lymphatic diseases. Whereas, Asia-Pacific is anticipated to exhibit highest CAGR over the forecast period 2021-2027. Because there is increase in incidence of breast cancer and growing patient awareness of the lymphedema treatment.
Major market player included in this report are:
PAUL HARTMANN AG
Convatec Inc.
SIGVARIS GROUP
Sanyleg Srl a socio unico
AIROS Medical, Inc.
Tactile Medical
BIOCOMPRESSION SYSTEMS
Lohmann & Rauscher GmbH & Co. KG
Mego Afek ltd.
ThermoTek, Cardinal Health
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Treatment Type:
Compression Therapy
Surgery
Drug Therapy
Laser Therapy
Others
By Type:
Primary Lymphedema
Secondary Lymphedema
By Affected Area:
Genital
Lower Extremity
Upper Extremity
Others
By Age Group:
Adult
Geriatric
By Route of Administration:
Oral
Injectable
Others
By End User
Hospitals
Ambulatory Surgical Centers
Speciality Clinics
Others
By Distribution Channel:
Direct Tender
Pharmacy Stores
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027
Target Audience of the Global Lymphedema Treatment Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Lymphedema Treatment Market, by Region, 2019-2027 (USD Billion)
1.2.2. Lymphedema Treatment Market, by Treatment Type, 2019-2027 (USD Billion)
1.2.3. Lymphedema Treatment Market, by Type, 2019-2027 (USD Billion)
1.2.4. Lymphedema Treatment Market, by Affected Area, 2019-2027 (USD Billion)
1.2.5. Lymphedema Treatment Market, by Age group, 2019-2027 (USD Billion)
1.2.6. Lymphedema Treatment Market, by Route of Administration, 2019-2027 (USD Billion)
1.2.7. Lymphedema Treatment Market, by End User, 2019-2027 (USD Billion)
1.2.8. Lymphedema Treatment Market, by Distribution Channel, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Lymphedema Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Lymphedema Treatment Market Dynamics
3.1. Lymphedema Treatment Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing cases of lymphedema diseases
3.1.2. Market Challenges
3.1.2.1. High cost of Surgery
3.1.3. Market Opportunities
3.1.3.1. Increasing R&D for drugs
Chapter 4. Global Lymphedema Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Lymphedema Treatment Market, by Treatment Type
6.1. Market Snapshot
6.2. Global Lymphedema Treatment Market by Treatment Type, Performance - Potential Analysis
6.3. Global Lymphedema Treatment Market Estimates & Forecasts by Treatment Type 2018-2027 (USD Billion)
6.4. Lymphedema Treatment Market, Sub Segment Analysis
6.4.1. Compression Therapy
6.4.2. Surgery
6.4.3. Drug Therapy
6.4.4. Laser Therapy
6.4.5. Others
Chapter 7. Global Lymphedema Treatment Market, by Type
7.1. Market Snapshot
7.2. Global Lymphedema Treatment Market by Type, Performance - Potential Analysis
7.3. Global Lymphedema Treatment Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
7.4. Lymphedema Treatment Market, Sub Segment Analysis
7.4.1. Primary Lymphedema
7.4.2. Secondary Lymphedema
Chapter 8. Global Lymphedema Treatment Market, by Affected Area
8.1. Market Snapshot
8.2. Global Lymphedema Treatment Market by Affected Area, Performance - Potential Analysis
8.3. Global Lymphedema Treatment Market Estimates & Forecasts by Affected Area 2018-2027 (USD Billion)
8.4. Lymphedema Treatment Market, Sub Segment Analysis
8.4.1. Genital
8.4.2. Lower Extremity
8.4.3. Upper Extremity
8.4.4. Others
Chapter 9. Global Lymphedema Treatment Market, by Age Group
9.1. Market Snapshot
9.2. Global Lymphedema Treatment Market by Age Group, Performance - Potential Analysis
9.3. Global Lymphedema Treatment Market Estimates & Forecasts by Age Group 2018-2027 (USD Billion)
9.4. Lymphedema Treatment Market, Sub Segment Analysis
9.4.1. Adult
9.4.2. Geriatric
Chapter 10. Global Lymphedema Treatment Market, by Route of Administration
10.1. Market Snapshot
10.2. Global Lymphedema Treatment Market by Route of Administration, Performance - Potential Analysis
10.3. Global Lymphedema Treatment Market Estimates & Forecasts by Route of Administration 2018-2027 (USD Billion)
10.4. Lymphedema Treatment Market, Sub Segment Analysis
10.4.1. Oral
10.4.2. Injectable
10.4.3. Others
Chapter 11. Global Lymphedema Treatment Market, by End User
11.1. Market Snapshot
11.2. Global Lymphedema Treatment Market by End User, Performance - Potential Analysis
11.3. Global Lymphedema Treatment Market Estimates & Forecasts by End User 2018-2027 (USD Billion)
11.4. Lymphedema Treatment Market, Sub Segment Analysis
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Speciality Clinics
11.4.4. Others
Chapter 12. Global Lymphedema Treatment Market, by Distribution Channel
12.1. Market Snapshot
12.2. Global Lymphedema Treatment Market by Distribution Channel, Performance - Potential Analysis
12.3. Global Lymphedema Treatment Market Estimates & Forecasts by Distribution Channel 2018-2027 (USD Billion)
12.4. Lymphedema Treatment Market, Sub Segment Analysis
12.4.1. Direct Tender
12.4.2. Pharmacy Stores
12.4.3. Others
Chapter 13. Global Lymphedema Treatment Market, Regional Analysis
13.1. Lymphedema Treatment Market, Regional Market Snapshot
13.2. North America Lymphedema Treatment Market
13.2.1. U.S. Lymphedema Treatment Market
13.2.1.1. Treatment Type breakdown estimates & forecasts, 2018-2027
13.2.1.2. Type breakdown estimates & forecasts, 2018-2027
13.2.1.3. Affected Area breakdown estimates & forecasts, 2018-2027
13.2.1.4. Age Group breakdown estimates & forecasts, 2018-2027
13.2.1.5. Route of Administration breakdown estimates & forecasts, 2018-2027
13.2.1.6. End User breakdown estimates & forecasts, 2018-2027
13.2.1.7. Distribution Channel breakdown estimates & forecasts, 2018-2027
13.2.2. Canada Lymphedema Treatment Market
13.3. Europe Lymphedema Treatment Market Snapshot
13.3.1. U.K. Lymphedema Treatment Market
13.3.2. Germany Lymphedema Treatment Market
13.3.3. France Lymphedema Treatment Market
13.3.4. Spain Lymphedema Treatment Market
13.3.5. Italy Lymphedema Treatment Market
13.3.6. Rest of Europe Lymphedema Treatment Market
13.4. Asia-Pacific Lymphedema Treatment Market Snapshot
13.4.1. China Lymphedema Treatment Market
13.4.2. India Lymphedema Treatment Market
13.4.3. Japan Lymphedema Treatment Market
13.4.4. Australia Lymphedema Treatment Market
13.4.5. South Korea Lymphedema Treatment Market
13.4.6. Rest of Asia Pacific Lymphedema Treatment Market
13.5. Latin America Lymphedema Treatment Market Snapshot
13.5.1. Brazil Lymphedema Treatment Market
13.5.2. Mexico Lymphedema Treatment Market
13.6. Rest of The World Lymphedema Treatment Market
Chapter 14. Competitive Intelligence
14.1. Top Market Strategies
14.2. Company Profiles
14.2.1. Paul Hartmann AG
14.2.1.1. Key Information
14.2.1.2. Overview
14.2.1.3. Financial (Subject to Data Availability)
14.2.1.4. Product Summary
14.2.1.5. Recent Developments
14.2.2. Convatec Inc.
14.2.3. SIGVARIS GROUP
14.2.4. Sanyleg Srl a socio unico
14.2.5. AIROS Medical, Inc.
14.2.6. Tactile Medical
14.2.7. BIOCOMPRESSION SYSTEMS
14.2.8. Lohmann & Rauscher GmbH & Co. KG
14.2.9. Mego Afek ltd.
14.2.10. ThermoTek, Cardinal Health
Chapter 15. Research Process
15.1. Research Process
15.1.1. Data Mining
15.1.2. Analysis
15.1.3. Market Estimation
15.1.4. Validation
15.1.5. Publishing
15.2. Research Attributes
15.3. Research Assumption
TABLE 1. Global Lymphedema Treatment market, report scope
TABLE 2. Global Lymphedema Treatment market estimates & forecasts by Region 2018-2027 (USD Billion)
TABLE 3. Global Lymphedema Treatment market estimates & forecasts by Treatment Type 2018-2027 (USD Billion)
TABLE 4. Global Lymphedema Treatment market estimates & forecasts by Type 2018-2027 (USD Billion)
TABLE 5. Global Lymphedema Treatment market estimates & forecasts by Affected Area 2018-2027 (USD Billion)
TABLE 6. Global Lymphedema Treatment market estimates & forecasts by Age Group 2018-2027 (USD Billion)
TABLE 7. Global Lymphedema Treatment market estimates & forecasts by Route of Administration 2018-2027 (USD Billion)
TABLE 8. Global Lymphedema Treatment market estimates & forecasts by End User 2018-2027 (USD Billion)
TABLE 9. Global Lymphedema Treatment market estimates & forecasts by Distribution Channel 2018-2027 (USD Billion)
TABLE 10. Global Lymphedema Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Lymphedema Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Lymphedema Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Lymphedema Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Lymphedema Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Lymphedema Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Lymphedema Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Lymphedema Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Lymphedema Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Lymphedema Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. U.S. Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. U.S. Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 22. U.S. Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 23. Canada Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 24. Canada Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. Canada Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. UK Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 27. UK Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. UK Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. Germany Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 30. Germany Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. Germany Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. RoE Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 33. RoE Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. RoE Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. China Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 36. China Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. China Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. India Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 39. India Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. India Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. Japan Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 42. Japan Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. Japan Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. RoAPAC Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 45. RoAPAC Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. RoAPAC Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. Brazil Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 48. Brazil Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. Brazil Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. Mexico Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 51. Mexico Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. Mexico Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. RoLA Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 54. RoLA Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. RoLA Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 56. Row Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 57. Row Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 58. Row Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 59. List of secondary sources, used in the study of global Lymphedema Treatment market
TABLE 60. List of primary sources, used in the study of global Lymphedema Treatment market
TABLE 61. Years considered for the study
TABLE 62. Exchange rates considered
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
